Contemporary Clinical Trials Communications (Mar 2017)

External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial

  • Sheila M. Bird,
  • John Strang,
  • Deborah Ashby,
  • John Podmore,
  • J. Roy Robertson,
  • Sarah Welch,
  • Angela M. Meade,
  • Mahesh K.B. Parmar

DOI
https://doi.org/10.1016/j.conctc.2017.01.006
Journal volume & issue
Vol. 5, no. C
pp. 100 – 106

Abstract

Read online

The prison-based N-ALIVE pilot trial had undertaken to notify the Research Ethics Committee and participants if we had reason to believe that the N-ALIVE pilot trial would not proceed to the main trial. In this paper, we describe how external data for the third year of before/after evaluation from Scotland's National Naloxone Programme, a related public health policy, were anticipated by eliciting prior opinion about the Scottish results in the month prior to their release as official statistics. We summarise how deliberations by the N-ALIVE Trial Steering-Data Monitoring Committee (TS-DMC) on N-ALIVE's own interim data, together with those on naloxone-on-release (NOR) from Scotland, led to the decision to cease randomization in the N-ALIVE pilot trial and recommend to local Principal Investigators that NOR be offered to already-randomized prisoners who had not yet been released.

Keywords